Distinguished in Pituitary Apoplexy

Dr. Eliza Geer

Endocrinology
Memorial Sloan Kettering Cancer Center
1275 York Ave, 
New York, NY 
Offers Telehealth

Distinguished in Pituitary Apoplexy
Memorial Sloan Kettering Cancer Center
1275 York Ave, 
New York, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Eliza Geer is an Endocrinologist in New York, New York. Dr. Geer is rated as a Distinguished provider by MediFind in the treatment of Pituitary Apoplexy. Her top areas of expertise are Cushing's disease, Cushing's syndrome, Pituitary Tumor, and Acromegaly.

Her clinical research consists of co-authoring 70 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in NY
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health First
  • HMO
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
MVP Health
  • EPO
  • PPO
Northwell Health
  • INSURANCE PLAN
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Memorial Sloan Kettering Cancer Center
1275 York Ave, New York, NY 10065
Call: 914-229-2827

Additional Areas of Focus

Dr. Geer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open-label Extension Study of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: June 19, 2025
Intervention Type: Drug
Study Drug: Levoketoconazole
Study Phase: Phase 3
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
An Open-label, Multi-center, Roll-over Study to Assess Long Term Safety in Patients With Endogenous Cushing's Syndrome Who Have Completed a Prior Novartis-sponsored Osilodrostat (LCI699) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Osilodrostat
Enrollment Status: Completed
Publish Date: December 18, 2024
Intervention Type: Drug
Study Drug: Osilodrostat
Study Phase: Phase 2
An Open Label, Multi-center Pasireotide Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment
An Open Label, Multi-center Pasireotide Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Pasireotide Study and Are Judged by the Investigator to Benefit From Continued Pasireotide Treatment
Enrollment Status: Completed
Publish Date: October 01, 2024
Intervention Type: Drug
Study Phase: Phase 4
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open Label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S, 4R-ketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: November 08, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: November 01, 2021
Intervention Type: Drug
Study Phase: Phase 3
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
An Open Label Study to Assess the Safety and Efficacy of COR-003 (Levoketoconazole) in the Treatment of Endogenous Cushing's Syndrome
Enrollment Status: Completed
Publish Date: April 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Phase III, Multi-center, Double-blind, Randomized Withdrawal Study of LCI699 Following a 24 Week, Single-arm, Open-label Dose Titration and Treatment Period to Evaluate the Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Enrollment Status: Completed
Publish Date: January 06, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
Enrollment Status: Completed
Publish Date: May 29, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 7 Less Clinical Trials

70 Total Publications

Prospective Assessment of Mood and Quality of Life in Cushing syndrome before and after Biochemical Control.
Prospective Assessment of Mood and Quality of Life in Cushing syndrome before and after Biochemical Control.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 15, 2025
View All 70 Publications
Similar Doctors
Distinguished in Pituitary Apoplexy
Dr. Jonas Leibowitz
Endocrinology
Distinguished in Pituitary Apoplexy
Dr. Jonas Leibowitz
Endocrinology

Endocrinology Diabetes And Osteoporosis Consultants LLP

770 McLean Ave Ste B, 
Yonkers, NY 
 (12.0 miles away)
914-650-2806
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonas Leibowitz is an Endocrinologist in Yonkers, New York. Dr. Leibowitz is rated as a Distinguished provider by MediFind in the treatment of Pituitary Apoplexy. His top areas of expertise are Hashimoto Thyroiditis, Type 2 Diabetes (T2D), Empty Sella Syndrome, and Pituitary Apoplexy.

Advanced in Pituitary Apoplexy
Dr. Sanjiv V. Kinkhabwala
Endocrinology
Advanced in Pituitary Apoplexy
Dr. Sanjiv V. Kinkhabwala
Endocrinology

Optum Medical Care PC

317 E 34th St, 
New York, NY 
 (1.5 miles away)
212-726-7400
Languages Spoken:
English
See accepted insurances

Sanjiv Kinkhabwala is an Endocrinologist in New York, New York. Dr. Kinkhabwala is rated as a Distinguished provider by MediFind in the treatment of Pituitary Apoplexy. His top areas of expertise are Obesity in Children, Hashimoto Thyroiditis, Hypothyroidism, and Pituitary Tumor.

Advanced in Pituitary Apoplexy
Dr. Georgiana Dobri
Endocrinology
Advanced in Pituitary Apoplexy
Dr. Georgiana Dobri
Endocrinology

Neurological Surgery

1305 York Ave Fl 9, 
New York, NY 
 (0.4 miles away)
929-458-8302
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Georgiana Dobri is an Endocrinologist in New York, New York. Dr. Dobri is rated as a Distinguished provider by MediFind in the treatment of Pituitary Apoplexy. Her top areas of expertise are Pituitary Tumor, Prolactinoma, Craniopharyngioma, Hypothalamic Tumor, and Endoscopic Transnasal Transsphenoidal Surgery.

VIEW MORE PITUITARY APOPLEXY DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Geer's expertise for a condition
ConditionClose
  • Elite
  • Acromegaly
    Dr. Geer is
    Elite
    . Learn about Acromegaly.
    See more Acromegaly experts
  • Cushing's disease
    Dr. Geer is
    Elite
    . Learn about Cushing's disease.
    See more Cushing's disease experts
  • Cushing's syndrome
    Dr. Geer is
    Elite
    . Learn about Cushing's syndrome.
    See more Cushing's syndrome experts
  • Hypothalamic Tumor
    Dr. Geer is
    Elite
    . Learn about Hypothalamic Tumor.
    See more Hypothalamic Tumor experts
  • Pituitary Tumor
    Dr. Geer is
    Elite
    . Learn about Pituitary Tumor.
    See more Pituitary Tumor experts
  • Prolactinoma
    Dr. Geer is
    Elite
    . Learn about Prolactinoma.
    See more Prolactinoma experts
  • Distinguished
  • Acromegaloid Facial Appearance Syndrome
    Dr. Geer is
    Distinguished
    . Learn about Acromegaloid Facial Appearance Syndrome.
    See more Acromegaloid Facial Appearance Syndrome experts
  • Addison's Disease
    Dr. Geer is
    Distinguished
    . Learn about Addison's Disease.
    See more Addison's Disease experts
  • Cushing's syndrome due to Adrenal Tumor
    Dr. Geer is
    Distinguished
    . Learn about Cushing's syndrome due to Adrenal Tumor.
    See more Cushing's syndrome due to Adrenal Tumor experts
  • Empty Sella Syndrome
    Dr. Geer is
    Distinguished
    . Learn about Empty Sella Syndrome.
    See more Empty Sella Syndrome experts
  • Exogenous Cushing's syndrome
    Dr. Geer is
    Distinguished
    . Learn about Exogenous Cushing's syndrome.
    See more Exogenous Cushing's syndrome experts
  • Gigantism
    Dr. Geer is
    Distinguished
    . Learn about Gigantism.
    See more Gigantism experts
View All 12 Distinguished Conditions
  • Advanced
  • Adrenal Gland Adenoma
    Dr. Geer is
    Advanced
    . Learn about Adrenal Gland Adenoma.
    See more Adrenal Gland Adenoma experts
  • Craniopharyngioma
    Dr. Geer is
    Advanced
    . Learn about Craniopharyngioma.
    See more Craniopharyngioma experts
  • Deafness Hypogonadism Syndrome
    Dr. Geer is
    Advanced
    . Learn about Deafness Hypogonadism Syndrome.
    See more Deafness Hypogonadism Syndrome experts
  • Diabetes Insipidus (DI)
    Dr. Geer is
    Advanced
    . Learn about Diabetes Insipidus (DI).
    See more Diabetes Insipidus (DI) experts
  • Ectopic Cushing's syndrome
    Dr. Geer is
    Advanced
    . Learn about Ectopic Cushing's syndrome.
    See more Ectopic Cushing's syndrome experts
  • Glucocorticoid Resistance
    Dr. Geer is
    Advanced
    . Learn about Glucocorticoid Resistance.
    See more Glucocorticoid Resistance experts
View All 21 Advanced Conditions
  • Experienced
  • Adrenal Cancer
    Dr. Geer is
    Experienced
    . Learn about Adrenal Cancer.
    See more Adrenal Cancer experts
  • Adrenocortical Carcinoma
    Dr. Geer is
    Experienced
    . Learn about Adrenocortical Carcinoma.
    See more Adrenocortical Carcinoma experts
  • Autosomal Recessive Hypotrichosis
    Dr. Geer is
    Experienced
    . Learn about Autosomal Recessive Hypotrichosis.
    See more Autosomal Recessive Hypotrichosis experts
  • Hypothyroidism
    Dr. Geer is
    Experienced
    . Learn about Hypothyroidism.
    See more Hypothyroidism experts
  • Infertility
    Dr. Geer is
    Experienced
    . Learn about Infertility.
    See more Infertility experts
  • Melasma
    Dr. Geer is
    Experienced
    . Learn about Melasma.
    See more Melasma experts
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.